30.05
Precedente Chiudi:
$28.85
Aprire:
$29.03
Volume 24 ore:
101.13K
Relative Volume:
0.47
Capitalizzazione di mercato:
$496.60M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-0.03%
1M Prestazione:
-29.86%
6M Prestazione:
-29.59%
1 anno Prestazione:
+0.00%
Claritev Corp Stock (CTEV) Company Profile
Nome
Claritev Corp
Settore
Industria
Telefono
212-780-2000
Indirizzo
7900 TYSONS ONE PLACE, MCLEAN
Confronta CTEV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
CTEV
Claritev Corp
|
30.05 | 476.76M | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
225.28 | 36.12B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
68.36 | 11.62B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
40.80 | 7.50B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
86.42 | 7.23B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
39.60 | 7.08B | 11.99B | 24.18M | 234.31M | 0.2956 |
Claritev Corp Stock (CTEV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-12 | Iniziato | Guggenheim | Buy |
| 2026-01-09 | Iniziato | Wells Fargo | Equal Weight |
| 2025-10-21 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-05-29 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-06-26 | Iniziato | Piper Sandler | Neutral |
| 2022-12-13 | Downgrade | Citigroup | Buy → Neutral |
| 2022-07-12 | Iniziato | Goldman | Neutral |
| 2021-10-04 | Ripresa | Citigroup | Buy |
| 2021-04-07 | Iniziato | B. Riley Securities | Buy |
| 2021-03-19 | Iniziato | Barclays | Equal Weight |
Mostra tutto
Claritev Corp Borsa (CTEV) Ultime notizie
Claritev partners with Kinetiq Health to tackle high-cost healthcare claims - Investing.com Nigeria
Claritev (CTEV) Enters Strategic Partnership with Kinetiq Health - GuruFocus
Data deal targets small set of costly claims driving employers’ health bills - Stock Titan
Claritev : and Kinetiq Health enter into strategic agreement to strengthen cost management and advance claims surveillance and diagnostic certainty - marketscreener.com
Claritev Corporation (NYSE:CTEV) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough - simplywall.st
Lobbying Update: $150,000 of CLARITEV (FORMERLY MULTIPLAN CORPORATION) lobbying was just disclosed - Quiver Quantitative
CTEV: Transformation, tech investment, and client focus drive growth and innovation in healthcare - TradingView — Track All Markets
Claritev outlines long-term growth strategy at healthcare conference - TipRanks
Claritev Corp Releases Investor Presentation at Healthcare Conference - TradingView — Track All Markets
Claritev: The Middleman In A Vertically Integrated Market (NYSE:CTEV) - Seeking Alpha
Claritev (CTEV) Price Target Decreased by 26.64% to 66.10 - Nasdaq
Aug Volume: What is Claritev Corporations P E ratio telling us2025 Macro Impact & Verified Short-Term Trading Plans - baoquankhu1.vn
Chipmakers Recap: How Claritev Corporation stock reacts to bond yieldsJuly 2025 Macro Moves & Consistent Return Investment Signals - Bộ Nội Vụ
Guggenheim Initiates Coverage on Claritev With Buy Rating, $43 Price Target - marketscreener.com
Guggenheim initiates coverage on Claritev stock with Buy rating By Investing.com - Investing.com UK
Guggenheim initiates coverage on Claritev stock with Buy rating - Investing.com
175,767 Options of Claritev Corporation are subject to a Lock-Up Agreement Ending on 12-JAN-2026. - marketscreener.com
Claritev Corporation (CTEV) Reports Q3 Loss, Tops Revenue Estimates - MSN
Claritev announces pricing of 1.5 million share secondary offering at $51.50 a piece - MSN
Why Claritev Corporation stock could rally in 20252025 Volatility Report & Daily Stock Trend Reports - Улправда
Does Claritev Corporation stock trade at a discount to peersTrend Reversal & AI Forecasted Entry/Exit Points - Улправда
Wells Fargo Initiates Coverage of Claritev (CTEV) with Equal-Weight Recommendation - Nasdaq
Claritev (CTEV): Citigroup Lowers Price Target while Maintaining Buy Rating | CTEV Stock News - GuruFocus
Wells Fargo initiates Claritev stock with Equal Weight rating, $33 target - Investing.com Nigeria
Wells Fargo Initiates Coverage on CTEV with Equal-Weight Rating - GuruFocus
Claritev price target lowered to $63 from $80 at Citi - TipRanks
What Catalysts Are Reshaping The Claritev (CTEV) Narrative On Growth Versus Leverage Risks - Yahoo Finance
Claritev Corporation Class A Common Stock (NY: CTEV - FinancialContent
Why Claritev Corporation Class stock stays resilientMarket Activity Summary & Reliable Price Breakout Alerts - ulpravda.ru
Can Claritev Corporation stock withstand economic slowdownJuly 2025 PostEarnings & Stepwise Trade Signal Guides - ulpravda.ru
Claritev initiated with an Equal Weight at Wells Fargo - TipRanks
Why Claritev Corporation stock remains a top recommendationJuly 2025 Analyst Calls & Weekly High Conviction Ideas - Улправда
Sentiment Review: Does Claritev Corporation stock trade at a discount to peersIPO Watch & Fast Entry High Yield Tips - Улправда
Can Claritev Corporation stock weather global recessionJuly 2025 Trade Ideas & Growth Oriented Trading Recommendations - Улправда
Star TribuneClaritev Corporation Class A Common Stock (NYSE:CTEV) Stock Quote - FinancialContent
Claritev Corporation to Present at J.P. Morgan Healthcare Conference - 01net
MarketsMedicine Hat News - FinancialContent
Claritev Ends Former CEO’s Strategic Advisory Role - The Globe and Mail
Claritev Corp announces end of Dale White’s strategic advisor role By Investing.com - Investing.com Australia
Claritev Corp announces end of Dale White’s strategic advisor role - Investing.com
Claritev Corp Announces Termination of Strategic Advisor Role - TradingView — Track All Markets
Claritev Corporation (NYSE: CTEV) ends Dale White advisory role; he remains director - Stock Titan
Claritev Corporation (CTEV) Stock Analysis: A 99% Upside Beckons as Analysts Rally Behind Healthcare Innovator - DirectorsTalk Interviews
Aug Levels: How buybacks impact Claritev Corporation stock value2025 Trading Volume Trends & Fast Entry High Yield Tips - Улправда
How buybacks impact Claritev Corporation stock value2025 Big Picture & Reliable Entry Point Trade Alerts - Улправда
Why Claritev Corporation stock remains undervalued2025 Sector Review & Fast Entry High Yield Tips - Улправда
Claritev Corp Azioni (CTEV) Dati Finanziari
Non sono disponibili dati finanziari per Claritev Corp (CTEV). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):